静脈内（IV）水分補給療法の世界市場レポート 2025年

静脈内（IV）水分補給療法市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.6％で44億米ドルに成長します。予測期間の成長は、消費者中心のパーソナライゼーション、企業のウェルネス・プログラムへの統合、予防的健康対策、フィットネス・ウェルネス・ツーリズムの成長、高齢化社会の需要に起因すると考えられます。予測期間における主な動向としては、倫理的で持続可能な調達、ホリスティックな健康保養、水分補給バーやラウンジ、メンタルウェルネスへの注目などが挙げられます。

慢性疾患の急増が予想されることから、静脈内（IV）水分補給療法市場は大きく成長する見通しです。この治療法には、ビタミンや必須栄養素の静脈内投与が含まれ、慢性疾患と闘う人々に大幅なエネルギー補給を提供します。2022年9月現在、世界保健機関（WHO）は年間死亡者数4,100万人という驚異的な数字を報告しており、世界の非感染性疾患（NCDs）または慢性疾患に起因する死亡者数の74％を占めています。特に、心血管疾患が1,790万人、がんが930万人、慢性呼吸器疾患が410万人、糖尿病が200万人の死亡に寄与しています。このような慢性疾患の増加は、静脈内（IV）水分補給療法市場の成長を促進する極めて重要な要因です。

高齢化人口の継続的な増加は、静脈内（IV）水分補給療法市場の拡大にさらに拍車をかける構えです。社会における高齢者の割合が増加していることが特徴であり、高齢化社会では、脱水症状に対処し、必要な栄養素を補給するための静脈内水分補給療法が効果的に行われ、全体的な健康と福祉が向上しています。2022年10月に世界保健機関（WHO）が発表した予測では、2030年までに世界の6人に1人が60歳以上になるとされています。60歳以上の人口の割合は、2020年の10億人から、この間に14億人に増加すると予想されています。さらに、60歳以上の世界人口は倍増し、2050年には21億人に達すると予想されています。その結果、高齢化人口の増加は静脈内（IV）水分補給療法市場の重要な促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界静脈内（IV）水分補給療法PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の静脈内（IV）水分補給療法市場：成長率分析
• 世界の静脈内（IV）水分補給療法市場の実績：規模と成長, 2019-2024
• 世界の静脈内（IV）水分補給療法市場の予測：規模と成長, 2024-2029, 2034F
• 世界静脈内（IV）水分補給療法総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の静脈内（IV）水分補給療法市場：サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫ブースター
• エネルギーブースター
• スキンケア
• 片頭痛
• その他のサービス
• 世界の静脈内（IV）水分補給療法市場：コンポーネント別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬用
• 非医薬品
• 世界の静脈内（IV）水分補給療法市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• ウェルネスセンターとスパ
• 在宅ヘルスケア
• その他のエンドユーザー
• 世界の静脈内（IV）水分補給療法市場免疫ブースターの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ビタミンC点滴
• 亜鉛点滴
• グルタチオン点滴
• 世界の静脈内（IV）水分補給療法市場、エネルギーブースターのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ビタミンB複合体点滴
• アミノ酸点滴
• 電解質溶液
• 世界の静脈内（IV）水分補給療法市場スキンケアのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 水分補給注入
• アンチエイジング注入
• デトックス注入
• 世界の静脈内（IV）水分補給療法市場片頭痛の種類によるサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鎮痛点滴
• マグネシウム点滴
• 水分補給注入
• 世界の静脈内（IV）水分補給療法市場、その他のサービスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 二日酔い緩和注入
• 減量点滴
• 運動パフォーマンス注入

第7章 地域別・国別分析

• 世界の静脈内（IV）水分補給療法市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の静脈内（IV）水分補給療法市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 静脈内（IV）水分補給療法市場：競合情勢
• 静脈内（IV）水分補給療法市場：企業プロファイル
  • Revitalist Overview, Products and Services, Strategy and Financial Analysis
  • JW Life Science Corporation Overview, Products and Services, Strategy and Financial Analysis
  • NextGen Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Liquid IV
• Medtronic Plc.
• Drip Hydration
• Amanta Healthcare Ltd.
• Becton Dickinson and Company
• Elixir
• Baxter International Inc.
• Otsuka Pharmaceutical Co. Ltd.
• Sippex IV bag
• REVIV
• Braun Melsungen AG
• The IV Doc Inc.
• Terumo Medical Corporation
• Grifols S.A.
• Harpal Clinic Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 静脈内（IV）水分補給療法市場2029：新たな機会を提供する国
• 静脈内（IV）水分補給療法市場2029：新たな機会を提供するセグメント
• 静脈内（IV）水分補給療法市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Intravenous (IV) hydration therapy is a simple medical procedure involving the insertion of a small IV into the arm to deliver fluids directly into the bloodstream. This method facilitates faster absorption of nutrients, fluids, medications, and blood, aiding in the body's treatment and recovery process by utilizing the circulatory system.

The primary service categories within intravenous (IV) hydration therapy encompass immune boosters, energy boosters, skin care treatments, migraine relief, and other specialized therapies. Immunity boosters are products designed to enhance the immune system and reduce susceptibility to illnesses. These products come in medicated and non-medicated forms and cater to diverse end-users, including hospitals and clinics, wellness centers and spas, home healthcare services, and other relevant facilities.

The intravenous(IV) hydration therapy market research report is one of a series of new reports from The Business Research Company that provides intravenous(IV) hydration therapy market statistics, including intravenous(IV) hydration therapy industry global market size, regional shares, competitors with an intravenous(IV) hydration therapy market share, detailed intravenous(IV) hydration therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the intravenous(IV) hydration therapy industry. This intravenous (IV) hydration therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravenous (IV) hydration therapy market size has grown strongly in recent years. It will grow from $2.82 billion in 2024 to $3.05 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to medical treatments and procedures, athletic and sports performance, clinical management of dehydration, recovery from illnesses, and mobile and concierge services

The intravenous (IV) hydration therapy market size is expected to see strong growth in the next few years. It will grow to $4.4 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to consumer-centric personalization, integration into corporate wellness programs, preventive health measures, growth in fitness and wellness tourism, and aging population demands. Major trends in the forecast period include ethical and sustainable sourcing, holistic health retreats, hydration bars and lounges, and a focus on mental wellness.

The anticipated surge in the prevalence of chronic diseases is poised to drive significant growth in the intravenous (IV) hydration therapy market. This therapeutic approach involves the administration of vitamins and essential nutrients intravenously, offering a substantial energy boost to individuals grappling with chronic diseases. As of September 2022, the World Health Organization reported a staggering 41 million annual deaths, accounting for 74% of fatalities attributed to non-communicable diseases (NCDs) or chronic ailments globally. Notably, cardiovascular diseases contributed to 17.9 million deaths, cancer to 9.3 million deaths, chronic respiratory diseases to 4.1 million deaths, and diabetes to 2.0 million deaths. This escalation in chronic disease prevalence is a pivotal factor propelling the growth of the intravenous (IV) hydration therapy market.

The continual rise in the aging population is poised to further fuel the expansion of the intravenous (IV) hydration therapy market. Characterized by an increasing proportion of elderly individuals in society, the aging population is effectively addressed by IV hydration therapy to combat dehydration and provide essential nutrients, thereby enhancing overall health and well-being. Projections from the World Health Organization in October 2022 indicated that, by 2030, one out of every six individuals globally would be 60 years old or older. The proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion during this period. Furthermore, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion by 2050. Consequently, the increasing aging population stands as a significant driver for the intravenous (IV) hydration therapy market.

The intravenous (IV) hydration therapy market is experiencing a notable trend towards product innovation, with major companies leveraging new technologies to maintain their market positions. An illustrative example occurred in September 2022 when Concierge Medical Consultants Inc, a Canada-based group of board-certified physicians specializing in private, discreet, and personalized healthcare, introduced Intravenous Vitamin Therapy (IV Therapy) to its services in Toronto and Vancouver. This addition included a novel IV hydration service featuring six variations of Vitamindrip products such as hydration, recovery, energy, cosmetics, diet and detox, and immune boost. The scientifically formulated Vitamin drip, administered intravenously, effectively addresses dehydration and various disorders such as migraines, acute muscle spasms, asthma, upper respiratory tract infections, chronic sinusitis, and seasonal allergic rhinitis.

Major players in the intravenous (IV) hydration therapy market are directing their efforts towards the development of sterile solutions, particularly CBD isolate, to meet the growing demand for CBD infusion and gain a competitive edge. CBD isolate, recognized as the purest form of cannabidiol, contains no additional cannabinoids or plant compounds. In a notable development in September 2023, Apex Labs CBD, a US-based company offering a diverse range of high-quality CBD products, launched Pico IV, a CBD isolate specifically designed for intravenous (IV) therapy. Pico IV's sterile solution ensures safe intravenous use, catering to the increasing demand for CBD infusion in the rapidly expanding IV hydration therapy market. Distinguished by the reduction of the CBD molecule size to a picometer, Pico IV offers maximum absorption and is exclusively available for online purchase to licensed IV therapy providers.

In May 2022, Fresenius Kabi AG, a prominent healthcare company based in Germany, completed the acquisition of Ivenix Inc. The financial details of the transaction were undisclosed. This strategic move by Fresenius Kabi AG is aimed at establishing a comprehensive and innovative portfolio of top-tier infusion treatment solutions specifically tailored for the American market. Ivenix Inc., based in the United States, is recognized for pioneering a new generation of intravenous (IV) hydration therapy. The acquisition aligns with Fresenius Kabi AG's commitment to enhancing and diversifying its offerings in the healthcare sector, particularly in the realm of infusion treatments.

Major companies operating in the intravenous (IV) hydration therapy market include Revitalist, JW Life Science Corporation, NextGen Healthcare, Pfizer Inc., Fresenius Kabi AG, Liquid IV, Medtronic Plc., Drip Hydration, Amanta Healthcare Ltd., Becton Dickinson and Company, Elixir, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Sippex IV bag, REVIV, Braun Melsungen AG, The IV Doc Inc., Terumo Medical Corporation, Grifols S.A., Harpal Clinic Ltd., Fosmo Med, Core IV Therapy LLC, Cryojuvenate UK Ltd., Hospira, Teleflex Incorporated, Sichuan Kelun Pharmaceutical Co.Ltd., ICU Medical Inc., Vygon SAS, Vifor Pharma Management AG

North America was the largest region in the intravenous (IV) hydration therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (iv) hydration therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the intravenous (iv) hydration therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The intravenous (IV) hydration therapy market includes revenues earned by entities by providing normal saline, half-normal saline, lactated ringers, dextrose, and related detoxification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravenous (IV) Hydration Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intravenous (iv) hydration therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravenous (iv) hydration therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intravenous (iv) hydration therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service: Immune Boosters; Energy Boosters; Skin Care; Migraine; Other Service
• 2) By Component: Medicated; Non-Medicated
• 3) By End-User: Hospitals And Clinics; Wellness Centers And Spas; Home Healthcare; Other End-Users
• Subsegments:
• 1) By Immune Boosters: Vitamin C Infusion; Zinc Infusion; Glutathione Infusion
• 2) By Energy Boosters: B-Complex Vitamins Infusion; Amino Acids Infusion; Electrolyte Solutions
• 3) By Skin Care: Hydration Infusion; Anti-Aging Infusion; Detox Infusion
• 4) By Migraine: Pain Relief Infusion; Magnesium Infusion; Hydration Infusion
• 5) By Other Services: Hangover Relief Infusion; Weight Loss Infusion; Athletic Performance Infusion
• Companies Mentioned: Revitalist; JW Life Science Corporation; NextGen Healthcare; Pfizer Inc.; Fresenius Kabi AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intravenous (IV) Hydration Therapy Market Characteristics

3. Intravenous (IV) Hydration Therapy Market Trends And Strategies

4. Intravenous (IV) Hydration Therapy Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Intravenous (IV) Hydration Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Intravenous (IV) Hydration Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Intravenous (IV) Hydration Therapy Market Growth Rate Analysis
• 5.4. Global Intravenous (IV) Hydration Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Intravenous (IV) Hydration Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Intravenous (IV) Hydration Therapy Total Addressable Market (TAM)

6. Intravenous (IV) Hydration Therapy Market Segmentation

• 6.1. Global Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immune Boosters
• Energy Boosters
• Skin Care
• Migraine
• Other Service
• 6.2. Global Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medicated
• Non-Medicated
• 6.3. Global Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Wellness Centers And Spas
• Home Healthcare
• Other End-Users
• 6.4. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Immune Boosters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vitamin C Infusion
• Zinc Infusion
• Glutathione Infusion
• 6.5. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Energy Boosters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• B-Complex Vitamins Infusion
• Amino Acids Infusion
• Electrolyte Solutions
• 6.6. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Skin Care, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydration Infusion
• Anti-Aging Infusion
• Detox Infusion
• 6.7. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Migraine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Relief Infusion
• Magnesium Infusion
• Hydration Infusion
• 6.8. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hangover Relief Infusion
• Weight Loss Infusion
• Athletic Performance Infusion

7. Intravenous (IV) Hydration Therapy Market Regional And Country Analysis

• 7.1. Global Intravenous (IV) Hydration Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Intravenous (IV) Hydration Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intravenous (IV) Hydration Therapy Market

• 8.1. Asia-Pacific Intravenous (IV) Hydration Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intravenous (IV) Hydration Therapy Market

• 9.1. China Intravenous (IV) Hydration Therapy Market Overview
• 9.2. China Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intravenous (IV) Hydration Therapy Market

• 10.1. India Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intravenous (IV) Hydration Therapy Market

• 11.1. Japan Intravenous (IV) Hydration Therapy Market Overview
• 11.2. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intravenous (IV) Hydration Therapy Market

• 12.1. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intravenous (IV) Hydration Therapy Market

• 13.1. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intravenous (IV) Hydration Therapy Market

• 14.1. South Korea Intravenous (IV) Hydration Therapy Market Overview
• 14.2. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intravenous (IV) Hydration Therapy Market

• 15.1. Western Europe Intravenous (IV) Hydration Therapy Market Overview
• 15.2. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intravenous (IV) Hydration Therapy Market

• 16.1. UK Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intravenous (IV) Hydration Therapy Market

• 17.1. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intravenous (IV) Hydration Therapy Market

• 18.1. France Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intravenous (IV) Hydration Therapy Market

• 19.1. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intravenous (IV) Hydration Therapy Market

• 20.1. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intravenous (IV) Hydration Therapy Market

• 21.1. Eastern Europe Intravenous (IV) Hydration Therapy Market Overview
• 21.2. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intravenous (IV) Hydration Therapy Market

• 22.1. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intravenous (IV) Hydration Therapy Market

• 23.1. North America Intravenous (IV) Hydration Therapy Market Overview
• 23.2. North America Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intravenous (IV) Hydration Therapy Market

• 24.1. USA Intravenous (IV) Hydration Therapy Market Overview
• 24.2. USA Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intravenous (IV) Hydration Therapy Market

• 25.1. Canada Intravenous (IV) Hydration Therapy Market Overview
• 25.2. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intravenous (IV) Hydration Therapy Market

• 26.1. South America Intravenous (IV) Hydration Therapy Market Overview
• 26.2. South America Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intravenous (IV) Hydration Therapy Market

• 27.1. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intravenous (IV) Hydration Therapy Market

• 28.1. Middle East Intravenous (IV) Hydration Therapy Market Overview
• 28.2. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intravenous (IV) Hydration Therapy Market

• 29.1. Africa Intravenous (IV) Hydration Therapy Market Overview
• 29.2. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intravenous (IV) Hydration Therapy Market Competitive Landscape And Company Profiles

• 30.1. Intravenous (IV) Hydration Therapy Market Competitive Landscape
• 30.2. Intravenous (IV) Hydration Therapy Market Company Profiles
  • 30.2.1. Revitalist Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. JW Life Science Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. NextGen Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

31. Intravenous (IV) Hydration Therapy Market Other Major And Innovative Companies

• 31.1. Liquid IV
• 31.2. Medtronic Plc.
• 31.3. Drip Hydration
• 31.4. Amanta Healthcare Ltd.
• 31.5. Becton Dickinson and Company
• 31.6. Elixir
• 31.7. Baxter International Inc.
• 31.8. Otsuka Pharmaceutical Co. Ltd.
• 31.9. Sippex IV bag
• 31.10. REVIV
• 31.11. Braun Melsungen AG
• 31.12. The IV Doc Inc.
• 31.13. Terumo Medical Corporation
• 31.14. Grifols S.A.
• 31.15. Harpal Clinic Ltd.

32. Global Intravenous (IV) Hydration Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intravenous (IV) Hydration Therapy Market

34. Recent Developments In The Intravenous (IV) Hydration Therapy Market

35. Intravenous (IV) Hydration Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Intravenous (IV) Hydration Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Intravenous (IV) Hydration Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Intravenous (IV) Hydration Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer